---
title: "EPHX1"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "# Gene: EPHX1"
tags: ['EPHX1', 'EpoxideHydrolase', 'GeneticVariations', 'DrugMetabolism', 'DiseaseRisk', 'Treatment', 'EH1Inhibitors', 'DrugResponse']
---

# Gene: EPHX1

## Summary

EPHX1 (Epoxide hydrolase 1) is a gene that provides instructions for making an enzyme that catalyzes the hydrolysis of epoxide compounds. This process converts toxic epoxides into more water-soluble diols, which can be excreted from the body.

## Function

The EPHX1 gene encodes the protein Epoxide Hydrolase 1 (EH1), which hydrolyzes epoxides by adding water across the epoxide-alkene linkage, producing the corresponding diols. EH1 plays a role in the metabolism of many xenobiotic compounds including polyaromatic hydrocarbons (PAHs), epoxides formed by the metabolism of drugs, and lipid epoxides.

## Gene information

- External IDs: 
    - HGNC: 3396
    - NCBI Entrez Gene: 2052 
    - Ensembl: ENSG00000102243
    - OMIM: 132810
    - UniProtKB/Swiss-Prot: P07099
- Genomic location: Chromosome 1 (1q42.1)
- Aliases: ECYT3, EPHX, HYL1

## Variations

### AA mutations

There are several known mutations in the EPHX1 gene that are associated with changes in enzymatic activity. Some notable ones are:

- R287Q (rs1051740): This variant causes a decrease in EH1 activity, resulting in reduced metabolism of some epoxide substrates.
- Y113H (rs2234922): This variant also leads to reduced enzyme activity, particularly for some PAH substrates.
- K55R (rs41272214): This variant is associated with increased EH1 activity.

### Somatic mutations

There are currently no known somatic mutations in the EPHX1 gene.

## Related diseases

Genetic variations in the EPHX1 gene have been implicated in several diseases, including:

- Asthma: EPHX1 gene variants have been associated with an increased risk of developing asthma and airway hyper-responsiveness.
- Cardiovascular disease: Some EPHX1 polymorphisms have been linked to an increased risk of atherosclerosis and other cardiovascular diseases.
- Cancer: EPHX1 variants have been associated with an increased risk of breast, lung, and bladder cancer.

## Treatment and prognosis

There are currently no specific treatments for EPHX1 gene mutations. However, understanding a patient's genetic variants in this gene may help predict their response to certain drugs or environmental toxins. Additionally, research is ongoing to develop EH1 inhibitors for potential cancer and inflammatory disease treatments.

## Drug response

Some drugs, such as carbamazepine and valproic acid, are metabolized by EH1. Patients with certain EPHX1 variants may have altered drug metabolism and therefore respond differently to these medications.

## References

- Nebert DW, Vasiliou V (2004). "Analysis of the glutathione S-transferase (GST) gene family". Hum. Genomics. 1 (6): 460–4.
- Vera-Aviles M, Rodriguez-Lara SQ, Nava-Quiroz KG, et al. (2019). "Genotype-phenotype association of EPHX1 polymorphisms and the susceptibility to acute lymphoblastic leukemia". Leuk. Lymphoma. 60 (5): 1341–1350.
- Smith G, Stanley LA (2018). "Epoxide hydrolases in the metabolism of arene and aliphatic compounds, drugs and carcinogens". Curr. Opin. Toxicol. 9: 46-54.

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**